Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
experimental approaches of the laboratory include molecular-, cellular-, and immunological-based techniques along with animal models of pathogenesis and treatment. Studies are carried out in biosafety level (BSL
-
The Klco lab is looking for a post-doctoral fellow interested in using mouse and human models to understand pediatric AML and MDS. We are part of the Department of Pathology and the Center
-
Postdoctoral Research Associate - Basic and Translational Research Training in Pediatric Classical H
classical hematology, with special emphasis on genomics, gene regulation, and cutting-edge experimental model systems and approaches to mechanistic cell and molecular biology. Trainees will greatly benefit
-
basis of these tumors, which now requires systematic efforts to translate the wealth of genomic discoveries into new experimental models and therapeutic advances. Postdoctoral fellows participating in
-
to respiratory viruses and T cell exhaustion during chronic infections and cancer. Ongoing studies leverage a wide array of model systems and techniques including novel mouse models of infection and cancer
-
efforts dedicated to elucidating the molecular mechanisms by which platelets, immune cells, and the extracellular matrix cooperate to promote metastasis. Ongoing studies leverage a wide array of model
-
a resilience performance modelling framework at the regional and European level. The place of employment is Hamburg. GERICS develops science-based prototype products and services in support to
-
that will be affiliated with one of six possible multidisciplinary projects. The ideal postdocs will have expertise in some of the following areas: computational modeling, computational biology, computational
-
multi-disciplinary approaches to answer these key questions including; immunology, oncology (in vitro model-organoid systems, ex vivo tissue culture), microbiology, next generation sequencing (16S seq
-
available single-cell sequencing data generated from patient samples and mouse models, we will enhance and apply machine-learning based algorithms to deconvolute bulk tumor RNA-seq samples to distinct immune